Page 34 - FBL AR 2019-20
P. 34

Fermenta Biotech Limited
           Annual Report 2019-20





          S TR ATEGIC   O u TL OOK
          Our performance ambition:


          Profitable and sustainable


          business growth




          6 ways in which
          Fermenta intends to enhance shareholder value



           Global alliances and              Backward                          Capacity
           acquisitions                      integration                       expansion

           Fermenta established a subsidiary   Fermenta implemented backward    Fermenta entered into a 99-year lease
           in Germany to enter into a contract   integration into the manufacture of   to acquire about 40,000 sq mtrs of land
           manufacturing relationship with a   cholesterol in the FY 2019-20. The   from the GIDC Authority in Ankleshwar
           European manufacturer specialising   Company uses cholesterol as a Key   (Sayakha). The Company intends to
           in Vitamin D3 technology. Fermenta is   Starting Material to manufacture its   commence manufacturing in the
           also open for acquisition opportunities   primary product Vitamin D.  foreseeable future.
           in the nutraceutical API space. It   Impact: The investment will result in   Impact: The new facility will focus on
           has conceived global alliances with   increased self-reliance and mitigation   capacity expansion of existing products
           strategic business partners to create a   of supply side risks.      and nutraceuticals
           robust and sustainable future.
           Impact: Asset light product
           outsourcing arrangement





           Disruptive                        Leveraging post-                  Customer-driven
           innovations                       amalgamation assets               product and service
                                             to finance growth
           The Company’s R&D pipeline is set to                                 The Company intends to build a
           widen its product mix by leveraging   The market value of real estate owned   product portfolio around consumer
           on existing strengths in the VMS   by the Company is estimated at over   demand and provide high-quality
           and related segments. The division   H500 crores, representing a large   ingredients with delivery excellence
           is addressing the growing global   portion of the Company’s market   to a valued clientele, emerging as not
           consumption of Vitamin D3 in human   valuation.                      just a supplier but a strategic long-term
           and animal feed applications.     Impact: The asset value will be    partner.
           Impact: The Company expects to    monetised and proceeds utilised for   Impact: The Company aims to increase
           diversify its presence in the food   the core business               its offerings and leverage long-standing
           segment and address the growing                                      relationships with customers
           dietary and nutritional supplements
           market














          32
   29   30   31   32   33   34   35   36   37   38   39